Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
J591 + IL-2 in Recurrent Prostate Cancer
NCT00040586Phase 2Completed
- Sponsor
- BZL Biologics LLC
- Modality
- Engineered Antibody Formats, Antibody-Radionuclide Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of huJ591 in prostate cancer (PCa), sponsored by BZL Biologics LLC. Status: completed.
02
Drugs
huJ591
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00040586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00040586.